Viewing Study NCT03011060


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-03-01 @ 9:58 AM
Study NCT ID: NCT03011060
Status: UNKNOWN
Last Update Posted: 2017-01-10
First Post: 2017-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer
Sponsor: The First Hospital of Jilin University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: JLUDBSCRH 001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View